PHMB: An effective antimicrobial in wound bioburden management

British Journal of Nursing

Volumn 21, Issue 12 SUPPL., 2012, Pages

  Butcher, Martyn ^a  

^a South West Wound Care Consultancy ^*  (United Kingdom)

Author keywords

Antimicrobial dressing; Bioburden; PHMB; Polihexanide; Wound infection

Indexed keywords

EID: 84865341492     PISSN: 09660461     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjon.2012.21.sup8.s16     Document Type: Article

References (91)

1. Akiyama H, Oono T, Saito M, Iwatsuki K (2004) Assessment of cadexomer iodine against Staphylococcus aureus biofilm in vivo and in vitro using confocal laser scanning microscopy. J Dermatol 31(7): 529-34 (Pubitemid 39045008)
2. Allen MJ, Morby AP, White GF (2004) Cooperativity in the binding of the cationic biocide polyhexamethylene biguanide to nucleic acids. Biochem Biophys Res Commun 318(2): 397-404 (Pubitemid 38553793)
3. Ansorg RA, Azem T, Fabry WH, Rath PM (2002) Influence of mucin on the activity of the antiseptic Lavasept against Staphylococcus aureus. Chemotherapy 48(3): 129-33
4. Bergin SM, Wraight P (2006) Silver based wound dressings and topical agents for treating diabetic foot ulcers. Cochrane Database Syst Rev Issue 1 Art. No.: CD005082. DOI: 10.1002/14651858.CD005082.pub2
5. Best Practice Statement (2011) The Use ofTopical Antimicrobial Agents in Wound Management. Wounds UK, London. Available at: http://www.wounds-uk.com/ best-practice-statements/best-practice-statement-the-use-of-topical- antisepticantimicrobial-agents-in-wound-management-2nd-edition
6. Brennan SS, Leaper DJ (1985) The effects of antiseptics on the healing wound: a study using the rabbit ear chamber. Br J Surg 72(10): 780-2 (Pubitemid 16193549)
7. Broxton P, Woodcock PM, Heatley F, Gilbert P (1984a) Interaction of some polyhexamethylene biguanides and membrane phospholipids in Escherichia coli.J Appl Bacteriol 57(1): 115-24 (Pubitemid 14037967)
8. Burd A, Kwok CH, Hung SC, Chan HS, Gu H, Lam WK, Huang L (2007) A comparative study of the cytotoxicity ofsilver-based dressings in monolayer cell, tissue explant and animal models. Wound Repair Regen 15(1): 94-104 (Pubitemid 46146668)
9. Cazzaniga A, Serralta V, Davis S, Orr R, Eaglstein W, Mertz PM (2002) The effect of an antimicrobial gauze dressing impregnated with 0.2-percent polyhexamethylene biguanide as a barrier to prevent Pseudomonas aeruginosa woundinvasion. Wounds 14(5): 169-76 (Pubitemid 41505199)
10. Chaby G, Senet P, Vaneau M, Martel P, Gauillaume JC et al (2007) Dressings for acute and chronic wounds: a systematic review. Arch Dermatol 143(10): 1297-304 (Pubitemid 47607683)
11. Clarke S (2003) The silver solution. Journal of Community Nursing 17(1): 25-8
12. Cookson BD (2000) Methicillin-resistant Staphylococcus aureus in the community: new battlefronts, or are the battles lost? Infect Control Hosp Epidemiol 21(6): 398-403
13. Cooper RA (2004) A review of the evidence for the use of topical antimicrobial agents in wound care. World Wide Wounds. Available online at: http://tinyurl.com/76m6ctg
14. Cooper RA (2007) Iodine revisited. Int Wound J4(2): 124-37
15. Cooper RA, Halas E, Molan PC (2002b) The efficacy ofhoney in inhibiting strains of Pseudomonas aeruginosa frominfected burns. J Burn Care Rehabil 23(6): 366-70 (Pubitemid 35453583)
16. Cooper RA, Molan PC, Harding KG (2002a) The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds. J Appl Microbiol 93(5): 857-63 (Pubitemid 35340889)
17. Daeschlein G, Assadian O, Bruck JC, Meinl C, Kramer A et al (2007) Feasibility and clinical applicability of polihexanide for treatment of second-degree burn wounds. Skin Pharmacol Physiol 20(6): 292-6 (Pubitemid 350014984)
18. Davies A, Bentley M, Field BS (1968) Comparisonoftheactionofvantocil, cetrimide and chlorhexidine on Escherichia coli and its spheroplasts and the protoplasts of Gram-positive bacteria. J Appl Bacteriol 31(4): 448-61
19. Davies A, Field BS (1969) Action of biguanides, phenols and detergents on Escherichia coli and its sphereoplasts. J Appl Bacteriol 32(2): 233-43
20. Demling R, DeSanti L (2001) The role of silver in wound healing: part 1. Effects ofsilver on wound management. Wounds: A Compendium of Clinical Research and Practice 13(1 Suppl A): 4-15
21. Denyer J (2009a) Epidermal bullosa and silver absorption in paediatrics. Presentation atWounds UK Conference, 11 November 2009, Harrogate
22. Denyer J (2009b) Management of the infant with epidermolysis bullosa. Infant 5(6): 168-71
23. Dissemond J, Gerber V, Kramer A, Riepe G, Strohal R et al (2010) A practice-oriented expert recommendation for treatment ofcritically colonised and locally infected wounds using polihexanide.J Tissue Viability 19(3): 106-15
24. Dow G (2001) Infection in chronic wounds. In: Krasner DL, Rodeheaver, GT, Sibbald RG eds. Chronic wound care: a clinical source book for healthcare professionals (3rd edn). HMP Communications Wayne, PA: 385-356
25. Dowsett C, Edwards-Jones V, Davies S (2004) Infection control for wound bed preparation. Br J Community Nurs 9(9s): 12-17
26. Drosou A, Falabella A, Kirsner R. (2003) Antiseptics on wounds: an area of controversy Wounds 15(5): 149-66 (Pubitemid 36886581)
27. Eberlein Th, Wild Th (2008) Approaches to therapy and an outlook on improving the clinical data situation, with a special focus on the polihexanide-containing Suprasorb X + PHMB Hydrobalance dressing. EWMA conference extended abstract.Available online at: http://tinyurl.com/cfs6rak
28. Edwards R, Harding KG (2004) Bacteria and wound healing. Curr Opin Infect Dis 17(2): 91-6 (Pubitemid 38453386)
29. European Wound Management Association (2006) Position Document: Management of wound infection. MEP Ltd, London
30. Galitz C, Hämmerle G, Signer M, Traber J, Eberlein T et al (2009) Polyhexanide versus silver wound dressings: first interim results of a controlled, randomized, prospective, multicentric study. Poster presentation. European Wound Management Association (EWMA) Conference, Helsinki.Available at: http://tinyurl.com/737n6go
31. Gilbert P (2006) Avoiding the resistance pitfall in infection control. Does the use ofantiseptic products contribute to the spread ofantibiotic resistance? Ostomy Wound Manage 52(10A Suppl): 1S-3S
32. Harbs N, Siebert J (2007) In vitro efficacy of octenidine and polihexanide against biofilms composed of Pseudomonas aeruginosa. GMS Krankenhaushyg Interdiszpl 2(2): Doc. 45 (20071228)
33. Hansson C (1998) The effects ofcadexomer iodine paste in the treatment of venous leg ulcers compared with hydrocolloid dressing and paraffin gauze dressing. Cadexomer Iodine Study Group. Int J Dermatol 37(5): 390-6 (Pubitemid 28231318)
34. Hunt TK, Hopf HW (1997) Wound healing and wound infection. What surgeons and anaesthesiologists can do. Surg Clin North Am 77(3): 587-606 (Pubitemid 27256036)
35. Ikeda T, Ledwith A, Bamford CH, Hann RA (1984) Interaction of a polymeric biguanide biocide with phospholipid membranes. Biochim Biophys Acta 769(1): 57-66
36. Ikeda T, Tazuke S, Watanabe M (1983) Interaction of biologically active molecules with phospholipid membranes. I. Fluorescence depolarization studies on the effect ofpolymeric biocide bearing biguanide groups in the main chain. Biochim Biophys Acta 735(3): 380-6
37. Kaehn K (2009) An in-vitro model for comparing the efficiency ofwound rinsing solutions.J Wound Care 18(6): 229-36
38. Karayil S, Deshpande SD, Koppikar GV (1998) Effect ofhoney on multidrug resistant organisms and its synergistic action with three common antibiotics. J Postgrad Med 44(4): 93-6 (Pubitemid 128526335)
39. Kingsley A (2001) A proactive approach to wound infection. Nurs Stand 15(30): 50-8
40. Kingsley A, Tradej M, Colbourn A, Kerr A, Bree-Aslan C (2009) Suprasorb X + PHMB: antimicrobial and Hydro Balance action in a new wound dressing. Wounds UK5(1):72-7
41. Klasen HJ (2000a) Historical review of the use ofsilver in the treatment of burns. I. Early uses. Burns 26(2): 117-30 (Pubitemid 30050604)
42. Klasen HJ (2000b) A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 26(2): 131-8 (Pubitemid 30050605)
43. Kramer A, Roth B, Müller G, Rudolph P, Klöcker N (2004) Influence of the antiseptic agents polyhexanide and octenidine on FL cells and on healing of experimental superficial aseptic wounds in piglets. A double-blind, randomised, stratified, controlled, parallel-group study. Skin Pharmacol Physiol 17(3): 141-6 (Pubitemid 38478889)
44. Kramer SA (1999) Effect ofpovidone-iodine on wound healing: a review. J Vasc Nurs 17(1): 17-23
45. Krebs FC, Miller SR, Ferguson ML, Labib M, Rando RF et al (2005) Polybiguanides, particularly polyethylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1. Biomed Pharmacother 59(8): 438-45 (Pubitemid 41383837)
46. Lee WR, Tobias KM, Bemis DA, Rohrbach BW (2004) In vitro efficacy of a polyhexamethylene biguanide-impregnated gauze dressing against bacteria found in veterinary patients. Vet Surg 33(4): 404-11 (Pubitemid 41783015)
47. Loh JV, Percival SL, Woods EJ, Williams NJ, Cochrane CA (2009) Silver resistance in MRSA isolated fromwound and nasal sources in humans and animals. Int Wound J 6(1): 32-8
48. Main RC (2008) Should chlorhexidine gluconate be used in wound cleansing? J Wound Care 11(3): 112-4
49. Michaels JA, Campbell B, King B, Palfreyman SJ, Shackley P et al (2009) Randomized controlled trial and cost-effectiveness analysis of silver-donating antimicrobial dressings for venous leg ulcers (VULCAN trial). Br J Surg 96(10): 1147-56
50. Molan PC (1999) The role of honey in the management of wounds. J Wound Care 8(8): 415-8
51. Molan PC (2001) Honey as a topical antibacterial agent for treatment of infected wounds. World Wide Wounds. Available at: http://tinyurl.com/ncs3k (last accessed 19April 2011)
52. Molan PC (2002) Re-introducing honey in the management ofwounds and ulcers: theory and practice. Ostomy Wound Manage 48(11): 28-40
53. Molan PC, Betts JA (2004) Clinical usage of honey as a wound dressing: an update. J Wound Care 13(9): 353-6
54. Moore K, Gray D (2007) Using PHMB antimicrobial to prevent wound infection. Wounds UK 3(2):96-102 (Pubitemid 47201772)
55. Mosti G, Mattaliano V, Schmitz M, Abel M (2008) Successful therapy of critically-colonised or locally infected wounds with a new hydrobalanced biocellulose-based wound dressing with polyhexanide on outpatients. Poster presentation. Wounds UK Conference, Harrogate.Available online at: http://tinyurl.com/cfs6rak
56. Mueller SW, Krebsbach LE (2008) Impact of an antimicrobial-impregnated gauze dressing on surgical site infections including methicillin-resistant Staphylococcus aureus infections. Am J Infect Control 36(9): 651-5
57. Müller G, Kramer A (2008) Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J Antimicrob Chemother 61(6): 1281-7 (Pubitemid 351753595)
58. Ousey K, McIntosh C (2009) Topical antimicrobial agents for the treatment ofchronic wounds. Br J Community Nurs 14(9): S6-S15
59. Parsons D, Bowler P, Myles V, Jones S (2005) Silver antimicrobial dressings in wound management: a comparison ofantibacterial, physical, and chemical characteristics. Wounds 17(8):222-32 (Pubitemid 41305917)
60. Percival SL, Bowler PG, Russell D (2005) Bacterial resistance to silver in wound care.J Hosp Infect 60(1): 1-7 (Pubitemid 40485843)
61. Pietsch T, Kraft R (2006) Antimikrobielle Wirksamkeit ausgewählter Substanzen für dieWasserdesinfektion in Dentaleinheiten mit Biofilmen. Aseptica 12(4): 3-4
62. Pinto F, Maillard JY Denyer SP (2010) Effect of surfactants, temperature, and sonication on the virucidal activity ofpolyhexamethylene biguanide against the bacteriophage MS2. Am J Infect Control 38(5): 393-8
63. Presterl E, Suchomel M, Eder M, Reichmann S, Lassnigg A et al (2007) Effects ofalcohols, povidone-iodine and hydrogen peroxide on biofilms of Staphylococcus epidermidis. J Antimicrob Chemother 60(2): 417-20 (Pubitemid 47243897)
64. Rhoads DD, Wolcott RD, Percival SL (2008) Biofilms in wounds: management strategies. J Wound Care 17(11): 502-8
65. Rosin M, Welk A, Kocher T, Majic-Todt A, Kramer A, Pitten FA (2002) The effect of a polyhexamethylene biguanide mouthrinse compared to an essential oil rinse and a chlorhexidine rinse on bacterial counts and 4-day plaque regrowth. J Clin Periodontol 29(5): 392-9 (Pubitemid 41697825)
66. Russell AD, Hugo WB (1994) Antimicrobial activity and action of silver. Prog Med Chem 31: 351-70
67. Russell AD (2002) Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria. J Appl Microbiol 92(suppl): 21S-35S
68. Schlüter B, Konig W (1990) Microbial pathogenicity and host defense mechanisms: crucial parameters of posttraumatic infections. Thorac Cardiovasc Surg 38(6): 339-47
69. Schnuch A, Geier J, Brasch J, Fuchs T, Pirker C et al (2000) Polyhexamethylene biguanide: a relevant contact allergen? Contact Dermatitis 42(5): 302-3 (Pubitemid 30219381)
70. Schnuch A, Geier J, Uter W, Basketter DA, Jowsey IR et al (2007) The biocide polyhexamethylene biguanide remains an uncommon contact allergen. Contact Dermatitis 56(4): 235-59
71. Schultz GS, Sibbald RG, Falanga V, Ayello EA, Dowsett C et al (2003)Wound bed preparation: a systematic approach to wound management. Wound Rep Regen 11(Suppl 1):S1-28
72. Seipp HM, Hofmann S, Hack A, Skowronsky A, Hauri A (2005) Wirksamkeit verschiedener Wundspüllösungen gegenüber Biofilmen. J Wound Healing (ZfW) 4: 160-4 (Pubitemid 41175414)
73. Sorensen OE, Cowland JB, Theilgaard-Mönch K, Liu L, Ganz T, Borregaard N (2003) Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes: a consequence of common growth factors. J Immunol 170(11): 5583-9 (Pubitemid 36617848)
74. Stotts NA (2004) Wound infection: diagnosis and management. In: Morison MJ, Ovington LG, Wilkie K eds. Chronic Wound Care: a problem-based learning approach. Mosby Publishing, Elsevier Ltd, London: 101-16
75. Thomson PD, Smith DJ Jr (1994) What is infection? Am J Surg 167(1a suppl): s7-s11 (Pubitemid 124006956)
76. Thomson PD.(2000) Immunology microbiology and the recalcitrant wound. Ostomy Wound Manage 46(1A suppl): 77S-82S
77. Thurman RB, Gerba CP (1989) The molecular mechanisms ofcopper and silver ion disinfection of bacteria and viruses. CRC Critical Reviews in Environmental Control 18(4):295-15
78. Wan AT, Conyers RAJ, Coombs CJ, Masterton JP (1991) Determination of silver in blood, urine and tissues ofvolunteers and burn patients. Clin Chem 37(10 Pt 1): 1683-7 (Pubitemid 21892727)
79. Wang XQ, Kempf M, Mott J, Chang HE, Francis R et al (2009) Silver absorption on burns after the application ofActicoat: data from pediatric patients and a porcine burn model. J Burn Care Res 30(2): 341-8
80. Warriner R, Burrell R (2005) Infection and the chronic wound: a focus on silver. Adv Skin Wound Care 18(Suppl 1): 2-12
81. Werthén M, Davoudi M, Sonesson A, Nitsche DP, Mörgelin M et al (2004) Pseudomonas aeruginosa-induced infection and degradation of human wound fluid and skin proteins ex vivo are eradicated by a synthetic cationic polymer. J Antimicrob Chemother 54(4): 772-9 (Pubitemid 39386730)
82. White RJ (2002) The use of topical antimicrobials in wound bioburden control. Br J Community Nurs 7(12 Silver Suppl 3): 20-6
83. White RJ, Cooper R, Kingsley A (2001)Wound colonisation and infection: the role oftopical antimicrobials. Br J Nurs 10(9): 563-78
84. Wiegand C, Abel M, Kramer A, Müller G, Ruth P et al (2008a) Viability and proliferation offibroblasts, keratinocytes and HaCaT-cells influenced by polihexanide. Poster presentationWounds UK Conference, Harrogate. Available online at: http://tinyurl.com/7xba8zw
85. Wiegand C, Abel M, Ruth P, Hipler U-C (2008b) Protective effect of polihexanide on HaCaT keratinocytes in co-culture with Staphylococcus aureus. Poster presentation at Wounds UK Conference, Harrogate. Available online at: http://tinyurl.com/cfs6rak
86. Wild Th, Buckner M, Payrich M, Schwarz Ch, Eberlein Th (2009) Prospective, randomized study for eradication of MRSA with polihexanide containing biocellulose dressing compared with polihexanide wound solution. Poster presentation. European Wound Management Association Conference, Helsinki.Available at: http://tinyurl.com/c3f8blg
87. Wilson JR, Mills JG, Prather ID, Dimitrijevich D (2005)A toxicity index of skin and wound cleansers used on in vitro fibroblasts and keratinocytes. Advances Skin Wound Care 18(7): 373-8
88. World Union of Wound Healing Societies (2008) Wound Infection in Clinical Practice: An International Consensus. Medical Education Partnership Ltd. London UK. Available at: http://tinyurl.com/89l943x
89. Wounds UK (2010) Consensus document: PHMB and its potential contribution to wound management. Wounds UK, Aberdeen.Available at: http://tinyurl. com/7cajnwf
90. Wright JB, Lam K, Olson ME, Burrell RE (2003) Is antimicrobial efficacy sufficient? A question concerning the benefits of new dressings. Wounds 15(3).Available online at: http://tinyurl.com/87faoou
91. Yasuda K, Ohmizo C, Katsu T (2003) Potassiumand tetraphenylphosphonium ion-selective electrodes for monitoring changes in the permeability of bacterial outer and cytoplasmic membranes. J Microbiol Methods 54(1): 111-5 (Pubitemid 36555801)